Hester to commercialize vaccines for animals

Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection

Panacea to produce 100 mn doses of Sputnik V vaccine

Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF

Our collective decisions will shape the future policy for equitable distribution of vaccine: Dr. Harsh Vardhan

India produces 60% of the world’s vaccine

Merck accelerates expansion plans for single-use products critical to manufacturing vaccines

The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.

Johnson & Johnson single-shot COVID-19 vaccine granted emergency use listing by WHO

The vaccine was 85 percent effective in preventing severe disease across all regions.

IDT and Ansa Biotechnologies join forces to push limits of DNA synthesis

The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability

Gradalis’ Vigil therapy dramatically extends survival in advanced ovarian cancer

The randomized, double-blind, placebo-controlled Phase 2b VITAL trial enrolled 91 patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer

Enginzyme and AGC unveil scalable process for key mRNA ingredient at Berlin Conference

GSK secures European nod for easier-to-use Shingrix prefilled syringe

The current two-vial format requires healthcare professionals to mix a lyophilised antigen with a liquid adjuvant before administration

PHARMEXCIL holds high-level talks with government to boost India’s pharma exports

India’s pharmaceutical sector stands at a pivotal inflection point